Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guanchao Pang
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0003-1742-7839
Observed ORCID:
0000-0003-1742-7839
OpenAlex ID:
A5015681988
Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
2020
·
Shumin Li
, Chengyan Zhang
, et al.
·
Frontiers in Immunology
·
46
PDF
Risk factors of immune checkpoint inhibitor-related pneumonitis after neoadjuvant immunochemotherapy for resectable NSCLC
2024
·
Zhirong Mao
, Guanchao Pang
, et al.
·
BMC Pulmonary Medicine
·
16
Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China
2019
·
Chengyan Zhang
, Guanchao Pang
, et al.
·
Journal of Immunology Research
·
11
PDF
CD34 evaluation of microvasculature in lung adenocarcinoma and its microvascular density predicts postoperative tumor recurrence
2025
·
Zijian Qiu
, Jiaji Wu
, et al.
·
Pathology & Oncology Research
·
8
PDF
Characteristics of mast cell infiltration in lung adenocarcinoma and its impact on prognosis
2024
·
Zijian Qiu
, Guanchao Pang
, et al.
·
Discover Oncology
·
8
Clinical outcomes associated with neoadjuvant therapy for the treatment of resectable non‐small cell lung cancer in real‐world practice
2024
·
Xiaojie Huang
, Guanchao Pang
, et al.
·
The Clinical Respiratory Journal
·
8
Integrase Interactor 1 (INI1) Deficiency in a Lung Cancer Patient Presents Nonresponse to Immunotherapy and Tazemetostat: A Case Report
2023
·
Xiuxiu Chen
, Jiaji Wu
, et al.
·
Cureus
·
3
PDF
Acquired Resistance to Afatinib Mediated by EGFR T790M in Lung Adenocarcinoma Patients Harboring EGFR-KDD: A Case Report and Literature Review
2026
·
Qian Liu
, Lu Lv
, et al.
·
Current Oncology
PDF
Show more works
View as search
Works count:
8
Citation count:
100
H-index:
6
I10-index:
3
Year
Topic
Type